TNF Adalimumab Biosimilar anti-Human, Unconjugated, Clone: Adalimumab.rMAb (also known as Adalimumab Biosimilar.rMAb), BD Phrmingen™

Biosimilar Monoclonal Antibody

Supplier:  BD Biosciences 569601

Catalog No. BDB569601

Description

TNF Adalimumab Biosimilar Monoclonal antibody specifically detects TNF Adalimumab Biosimilar in Human samples. It is validated for ELISA|Neutralization

Specifications

• Antigen: TNF Adalimumab Biosimilar
• Classification: Monoclonal
• Concentration: 1.0 mg/mL
• Formulation: No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2 μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001 ng/μg) of protein as determined by the LAL assay.
• Immunogen: Human TNF
• Quantity: 0.5 mg
• Primary or Secondary: Primary
• Target Species: Human
• Form: Liquid

• Applications: ELISA, Neutralization
• Clone: Adalimumab.rMAb (also known as Adalimumab Biosimilar.rMAb)
• Conjugate: Unconjugated
• Gene Alias: TNF; TNF-a; TNF-alpha; TNFA; TNFSF2
• Purification Method: Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 7124
• Content And Storage: Store undiluted at 4°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
• Isotype: IgG1 κ